ascletis inc

Roche, Ascletis To Bring Hepatitis C Drug Danoprevir Into China

Roche and Ascletis have entered into a collaboration to develop and commercialize Roche’s investigational Hepatitis C drug danoprevir in China.

First Chinese Investor-Backed Drug Maker To Operate In U.S. & China

The Hamner Institutes for Health Sciences and Ascletis, Inc. have signed a formal MOU towards a large-scale joint venture between the two parties.